Neurturin Human

<strong>Neurturin Human</strong>_x000D_ <strong>Catalog number:</strong> B2018827_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~12 kDa_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20¬∞C_x000D_ <strong>Keywords:</strong> Neurturin, NRTN_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Axelsen TM, Woldbye DPD. Gene Therapy for Parkinson's Disease, An¬†Update J Parkinsons Dis. 2018;8(2):195-215._x000D_ 2: Liu W, Rask-Andersen H. Immunohistological analysis of neurturin and its receptors in human cochlea Auris Nasus Larynx. 2014 Apr;41(2):172-8._x000D_ 3: Hickey P, Stacy M. AAV2-neurturin (CERE-120) for Parkinson's disease Expert Opin Biol Ther. 2013 Jan;13(1):137-45._x000D_ 4: Xi G, Esfandiary R, Sacramento CB, Jouihan H, Sharma A, Roth R, Linke T. Refolding and purification of cGMP-grade recombinant human neurturin from Escherichia coli inclusion bodies Protein Expr Purif. 2020 Apr;168:105552._x000D_ 5: Airavaara M, Voutilainen MH, Wang Y, Hoffer B. Neurorestoration Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1(0 1):S143-6._x000D_ 6: Sato S, Suzuki Y, Kikuchi M, Rikimaru M, Saito J, Shibata Y. Sputum Neurturin Levels in Adult Asthmatic Subjects J Asthma Allergy. 2023 Aug 31;16:889-901._x000D_ 7: Connolly E, Morgan DJ, Franklin M, Simpson A, Shah R, Brand OJ, Jagger CP, Casulli J, Mohamed K, Grabiec AM, Hussell T. Neurturin regulates the lung-resident macrophage inflammatory response to viral infection Life Sci Alliance. 2020 Oct 5;3(12):e202000780._x000D_ 8: Chu Y, Kordower JH. Post-Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10‚ÄâYears CERE120 Delivery Mov Disord. 2023 Sep;38(9):1728-1736._x000D_ 9: Sandmark J, Dahl G, √ñster L, Xu B, Johansson P, Akerud T, Aagaard A, Davidsson P, Bigalke JM, Winzell MS, Rainey GJ, Roth RG. Structure and biophysical characterization of the human full-length neurturin-GFRa2 complex: A role for heparan sulfate in signaling J Biol Chem. 2018 Apr 13;293(15):5492-5508._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/22926166">10: Bartus RT, Baumann TL, Brown L, Kruegel BR, Ostrove JM, Herzog CD. Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating "clinical proof-of-concept" for AAV-neurturin (CERE-120) in Parkinson's disease Neurobiol Aging. 2013 Jan;34(1):35-61. </a>_x000D_ _x000D_ <strong>Products Related to Neurturin Human can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>